Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer (TAPS)
This study is ongoing, but not recruiting participants.
Sponsor:
University of Washington
Collaborators:
GlaxoSmithKline
AstraZeneca
Information provided by (Responsible Party):
Bruce Montgomery, University of Washington
ClinicalTrials.gov Identifier:
NCT00298155
First received: February 27, 2006
Last updated: January 6, 2012
Last verified: January 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | February 2012 |
| Primary Completion Date: | June 2010 (Final data collection date for primary outcome measure) |